Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future
The theranostic approach in oncology holds significant importance in personalized medicine and stands as an exciting field of molecular medicine. Significant achievements have been made in this field in recent decades, particularly in treating neuroendocrine tumors using 177-Lu-radiolabeled somatost...
Main Authors: | William Echavidre, Daniel Fagret, Marc Faraggi, Vincent Picco, Christopher Montemagno |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/19/4839 |
Similar Items
-
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
by: William Echavidre, et al.
Published: (2022-05-01) -
Editorial: A year in review: discussions in nuclear medicine
by: Domenico Albano, et al.
Published: (2024-02-01) -
Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine
by: Christopher Montemagno, et al.
Published: (2020-03-01) -
Theranosticsin nuclear medicine and oncology
by: Sergio Baldari, et al.
Published: (2019-04-01) -
Cancer nanomedicine: a review of recent success in drug delivery
by: Stephanie Tran, et al.
Published: (2017-12-01)